You just read:

Research and Markets - Global $2.47 Billion Acquired Hemophilia Treatment Market, 2023: Key Players are Baxalta, Novo Nordisk, Biogen, Pfizer & F. Hoffman La Roche

News provided by

Research and Markets

21 Apr, 2017, 16:30 ET